In this novel study, we have for the first time identified evolutionarily conserved capsid residues in an individual chronically infected with norovirus (GGII.3). From 2000 to 2003, a total of 147 P1-1 and P2 capsid sequences were sequenced and investigated for evolutionarily conserved and functionally important residues by the evolutionary trace (ET) algorithm. The ET algorithm revealed more absolutely conserved residues (ACR) in the P1-1 domain (47/53, 88 %) as compared with the P2 domain (86/133, 64 %). The capsid P1-1 and P2 domains evolved in time-dependent manner, with a distinct break point observed between autumn/winter of year 2000 (isolates P1, P3 and P5) and spring to autumn of year 2001 (isolates P11, P13 and P15), which presumably coincided with a change of clinical symptoms. Furthermore, the ET analysis revealed a similar receptor-binding pattern as reported for Norwalk and VA387 strains, with the CS-4 and CS-5 patch (Norwalk strain) including residues 329 and 377 and residues 306 and 310, respectively, all being ACR in all partitions. Most interesting was that residues 343, 344, 345, 374, 390 and 391 of the proposed receptor A and B trisaccharide binding site (VA387 strain) within the P2 domain remained ACR in all partitions, presumably because there was no selective advantage to alter the histo blood group antigens (HBGA) receptor binding specificity. In conclusion, this study provides novel insights to the evolutionary process of norovirus during chronic infection.
BullR. A.,
HansmanG. S.,
ClancyL. E.,
TanakaM. M.,
RawlinsonW. D.,
WhiteP. A.2005; Norovirus recombination in ORF1/ORF2 overlap. Emerg Infect Dis 11:1079–1085[CrossRef]
CaoS.,
LouZ.,
TanM.,
ChenY.,
LiuY.,
ZhangZ.,
ZhangX. C.,
JiangX.,
LiX.,
RaoZ.2007; Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol 81:5949–5957[CrossRef]
ChakravartyS.,
HutsonA. M.,
EstesM. K.,
PrasadB. V.2005; Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol 79:554–568[CrossRef]
DomingoE.,
BaranowskiE.,
Ruiz-JaraboC. M.,
Martin-HernandezA. M.,
SaizJ. C.,
EscarmisC.1998; Quasispecies structure and persistence of RNA viruses. Emerg Infect Dis 4:521–527[CrossRef]
GallimoreC. I.,
LewisD.,
TaylorC.,
CantA.,
GenneryA.,
GrayJ. J.2004; Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH. J Clin Virol 30:196–204[CrossRef]
GlassR. I.,
NoelJ.,
AndoT.,
FankhauserR.,
BelliotG.,
MountsA.,
ParasharU. D.,
BreseeJ. S.,
MonroeS. S.2000; The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J Infect Dis 181:Suppl. 2S254–S261[CrossRef]
InnisC. A.,
ShiJ.,
BlundellT. L.2000; Evolutionary trace analysis of TGF-beta and related growth factors: implications for site-directed mutagenesis. Protein Eng 13:839–847[CrossRef]
LichtargeO.,
BourneH. R.,
CohenF. E.1996a; An evolutionary trace method defines binding surfaces common to protein families. J Mol Biol 257:342–358[CrossRef]
LichtargeO.,
BourneH. R.,
CohenF. E.1996b; Evolutionarily conserved Galphabetagamma binding surfaces support a model of the G protein-receptor complex. Proc Natl Acad Sci U S A 93:7507–7511[CrossRef]
LindesmithL.,
MoeC.,
MarionneauS.,
RuvoenN.,
JiangX.,
LindbladL.,
StewartP.,
LePenduJ.,
BaricR.2003; Human susceptibility and resistance to Norwalk virus infection. Nat Med 9:548–553[CrossRef]
LindesmithL. C.,
DonaldsonE. F.,
LobueA. D.,
CannonJ. L.,
ZhengD. P.,
VinjeJ.,
BaricR. S.2008; Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 5:e31[CrossRef]
NilssonM.,
HedlundK. O.,
ThorhagenM.,
LarsonG.,
JohansenK.,
EkspongA.,
SvenssonL.2003; Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J Virol 77:13117–13124[CrossRef]
SiebengaJ. J.,
VennemaH.,
RenckensB.,
de BruinE.,
van der VeerB.,
SiezenR. J.,
KoopmansM.2007; Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006. J Virol 81:9932–9941[CrossRef]
SowaM. E.,
HeW.,
SlepK. C.,
KercherM. A.,
LichtargeO.,
WenselT. G.2001; Prediction and conformation of a site critical for effector regulation of RGS domain activity. Nat Struct Biol 8:234–237[CrossRef]
TanM.,
HuangP.,
MellerJ.,
ZhongW.,
FarkasT.,
JiangX.2003; Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol 77:12562–12571[CrossRef]
ThompsonJ. D.,
HigginsD. G.,
GibsonT. J.1994; clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680[CrossRef]